Abilify MyCite

Product NDC
59148-029
11-digit product format
591480029
Labeler code
59148
Product ID
59148-029_3cbd66b3-7c90-44fc-9c44-3f290e6144e6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ARIPIPRAZOLE
Dosage form
TABLET WITH SENSOR
Route
ORAL
Labeler
Otsuka America Pharmaceutical, Inc.
Application
NDA207202
Marketing category
NDA
Marketing start
2018-01-31
Marketing end
0000-00-00
Substance
ARIPIPRAZOLE
Active strength
2 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59148-029-61EA - Each59148-0298487ce99-f9df-4085-a334-1872289c880512021-06-02
59148-029-72EA - Each59148-029b514fcaf-0d4a-4828-b738-0f308a223ddb12021-06-02
59148-029-85EA - Each59148-029f9506495-fa1a-4989-bbb4-5dd2dc287dde12018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59148-029ABILIFY MYCITE (ARIPIPRAZOLE) TABLET WITH SENSOR [OTSUKA AMERICA PHARMACEUTICAL, INC.]16Legacy NDC20250202_e8787c3f-5e41-42d1-8091-44b56346620f.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
59148-029-61591480029611 BOTTLE in 1 KIT (59148-029-61) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13) 1 bottle2020-12-190000-00-00NoNoCurrent
59148-029-72591480029721 BOTTLE in 1 KIT (59148-029-72) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13) 1 bottle2020-12-190000-00-00NoNoCurrent
59148-029-85591480029851 BOTTLE in 1 KIT (59148-029-85) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-029-13) 1 bottle2018-01-310000-00-00NoNoCurrent
59148-029-90591480029901 BOTTLE in 1 KIT (59148-029-90) > 7 TABLET WITH SENSOR in 1 BOTTLE (59148-029-07) 1 bottle2018-01-310000-00-00NoNoCurrent